Anti-Mullerian hormone levels in female cancer patients of reproductive age in Indonesia: A cross-sectional study.

ABSTRACT: Background: Efforts in reproductive preservation for cancer patients have become one of the important aspects of cancer management. In fact, decline in reproductive function is known to occur after exposure to anti-cancer treatments. Measuring anti-Müllerian hormone (AMH) levels is known to be the best parameter in predicting ovarian reserves, which indicates reproductive function. In total, 68% of cancer survivors of reproductive age who underwent anti-cancer treatments suffer from infertility. Meanwhile, ovarian reserves also decrease with increasing age. There is ongoing debate on whether the ovarian reserves of cancer patients could be reduced long before exposure to anti-cancer therapy. Therefore, it is important to know whether ovarian reserves in cancer patients decrease before or a

SUBMITTER: Harzif AK 

PROVIDER: S-EPMC7059784 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature